• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法属圭亚那镰状细胞病患者感染新型冠状病毒肺炎的临床结局

Clinical outcomes of COVID-19 in patients with sickle cell disease in French Guiana.

作者信息

Elenga Narcisse, Ntab Baltazar, Mafema Missindu Joddy, Thomas Boizan Noelis, Abassi Alio

机构信息

Service de Pédiatrie, Centre Hospitalier de Cayenne, Rue des Flamboyants, BP 6006, 97306 Cayenne, Cedex, Guiana, France.

Centre de Reference de La Drépanocytose, Centre Hospitalier de Cayenne, Rue des Flamboyants, BP 6006, 97306, Cayenne, Cedex, Guiana, France.

出版信息

Heliyon. 2024 May 31;10(11):e32017. doi: 10.1016/j.heliyon.2024.e32017. eCollection 2024 Jun 15.

DOI:10.1016/j.heliyon.2024.e32017
PMID:38868053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11168310/
Abstract

OBJECTIVES

French Guiana also suffered concrete epidemiological consequences of the SARS-CoV2 epidemic. These regions are home to a large number of sickle cell patients who are at risk of developing severe forms of COVID-19. This study aimed to describe the characteristics and prognosis of patients with sickle disease infected with SARS-CoV2 during the first and second epidemic waves of 2020 in French Guiana.

DESIGN

We conducted a multicenter, retrospective cohort study that included sickle cell patients followed up in French Guiana.

RESULTS

Among the 79 patients infected with SARS-CoV2, there were 26 children <18 years. Forty-two patients were hospitalized and 37 were outpatients. Respiratory illness (38 %), vaso-occlusive crises (18 %), and acute chest syndrome (8 %) were the main causes of hospitalization. There were two cases of pulmonary embolism and one case of deep limb thrombosis. Seven patients were transferred to the ICU. Of these, three received mechanical ventilation, and two died. The deceased patients had the SS phenotype (a 16-year-old boy and a 32-year-old man), both of whom exhibited severe pneumonitis complicated by COVID-19.

CONCLUSION

Despite the two deaths, the overall outcome was favorable.

摘要

目的

法属圭亚那也遭受了新冠病毒疫情的具体流行病学后果。这些地区有大量镰状细胞病患者,他们有发展为重症新冠肺炎的风险。本研究旨在描述2020年法属圭亚那第一波和第二波疫情期间感染新冠病毒的镰状细胞病患者的特征和预后。

设计

我们开展了一项多中心回顾性队列研究,纳入了在法属圭亚那接受随访的镰状细胞病患者。

结果

在79例感染新冠病毒的患者中,有26名儿童年龄小于18岁。42例患者住院,37例为门诊患者。呼吸系统疾病(38%)、血管闭塞性危机(18%)和急性胸综合征(8%)是住院的主要原因。有2例肺栓塞和1例下肢深静脉血栓形成。7例患者被转入重症监护病房。其中,3例接受了机械通气,2例死亡。死亡患者具有SS基因型(一名16岁男孩和一名32岁男性),两人均表现为严重肺炎并伴有新冠肺炎。

结论

尽管有2例死亡,但总体结果是良好的。

相似文献

1
Clinical outcomes of COVID-19 in patients with sickle cell disease in French Guiana.法属圭亚那镰状细胞病患者感染新型冠状病毒肺炎的临床结局
Heliyon. 2024 May 31;10(11):e32017. doi: 10.1016/j.heliyon.2024.e32017. eCollection 2024 Jun 15.
2
Air Drep-A Retrospective Study Evaluating the Influence of Weather Conditions and Viral Epidemics on Vaso-Occlusive Crises in Patients with Sickle Cell Disease Living in French Guiana.《空气 Drepanocytes:一项评估法属圭亚那镰状细胞病患者血管阻塞性危象与天气条件和病毒流行之间关系的回顾性研究》
Int J Environ Res Public Health. 2019 Jul 31;16(15):2724. doi: 10.3390/ijerph16152724.
3
Dengue in hospitalized children with sickle cell disease: A retrospective cohort study in the French departments of America.镰状细胞病住院患儿中的登革热:法属美洲的回顾性队列研究。
J Infect Public Health. 2020 Feb;13(2):186-192. doi: 10.1016/j.jiph.2019.07.015. Epub 2019 Sep 20.
4
[Sickle cell disease in French Guiana: assessing 30 years of neonatal screening (1992-2021)].[法属圭亚那的镰状细胞病:评估30年的新生儿筛查(1992 - 2021年)]
Med Trop Sante Int. 2024 Feb 13;4(1). doi: 10.48327/mtsi.v4i1.2024.488. eCollection 2024 Mar 31.
5
Characteristics, outcome, duration of hospitalization, and cycle threshold of patients with COVID-19 referred to four hospitals in Babol City: a multicenter retrospective observational study on the fourth, fifth, and sixth waves.巴博勒市 4 家医院转诊的 COVID-19 患者的特征、结局、住院时间和循环阈值:第四、五、六波的多中心回顾性观察研究。
BMC Infect Dis. 2024 Jan 6;24(1):55. doi: 10.1186/s12879-023-08939-w.
6
Sickle cell disease patients with COVID-19 in Guadeloupe: Surprisingly favorable outcomes.瓜德罗普岛患有新冠病毒疾病的镰状细胞病患者:令人惊讶的良好结果。
EJHaem. 2022 May 4;3(3):636-643. doi: 10.1002/jha2.449. eCollection 2022 Aug.
7
Low Stroke Risk in Children With Sickle Cell Disease in French Guiana: A Retrospective Cohort Study.法属圭亚那镰状细胞病患儿中风风险低:一项回顾性队列研究。
Front Med (Lausanne). 2022 Jun 28;9:851918. doi: 10.3389/fmed.2022.851918. eCollection 2022.
8
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
9
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
10
Influence of beta-cluster haplotypes, alpha-gene status and UGTA1 polymorphism on clinical and hematological data in sickle-cell disease children from French Guiana.法属圭亚那镰状细胞病儿童的β-簇单倍型、α-基因状态和 UGTA1 多态性对临床和血液学数据的影响。
PLoS One. 2020 Sep 3;15(9):e0238691. doi: 10.1371/journal.pone.0238691. eCollection 2020.

本文引用的文献

1
Impact of the SARS-CoV-2 infection in individuals with sickle cell disease: an integrative review.2019冠状病毒病感染对镰状细胞病患者的影响:一项综合综述。
Front Med (Lausanne). 2023 May 2;10:1144226. doi: 10.3389/fmed.2023.1144226. eCollection 2023.
2
Impact of COVID-19 infection among indian sickle cell disease patients.2019冠状病毒病感染对印度镰状细胞病患者的影响。
Indian J Public Health. 2023 Jan-Mar;67(1):112-116. doi: 10.4103/ijph.ijph_1230_22.
3
The burden of COVID-19 in French Guiana: Vaccine-averted deaths, hospitalizations and costs.法属圭亚那的新冠疫情负担:疫苗避免的死亡、住院情况及成本。
Vaccine X. 2023 Apr;13:100271. doi: 10.1016/j.jvacx.2023.100271. Epub 2023 Feb 11.
4
Sickle cell disease patients with COVID-19 in Guadeloupe: Surprisingly favorable outcomes.瓜德罗普岛患有新冠病毒疾病的镰状细胞病患者:令人惊讶的良好结果。
EJHaem. 2022 May 4;3(3):636-643. doi: 10.1002/jha2.449. eCollection 2022 Aug.
5
COVID-19 Vaccine Perception and Hesitancy Among Patients With Sickle Cell Disease in the Western Region of Saudi Arabia.沙特阿拉伯西部地区镰状细胞病患者对COVID-19疫苗的认知与犹豫
Cureus. 2022 Jan 8;14(1):e21026. doi: 10.7759/cureus.21026. eCollection 2022 Jan.
6
Risk factors for severe COVID-19 in hospitalized sickle cell disease patients: A study of 319 patients in France.住院镰状细胞病患者发生重症 COVID-19 的危险因素:法国 319 例患者的研究。
Am J Hematol. 2022 Mar 1;97(3):E86-E91. doi: 10.1002/ajh.26432. Epub 2021 Dec 18.
7
Characteristics of SARS-CoV-2 and COVID-19.SARS-CoV-2 和 COVID-19 的特征。
Nat Rev Microbiol. 2021 Mar;19(3):141-154. doi: 10.1038/s41579-020-00459-7. Epub 2020 Oct 6.
8
Sickle cell disease and COVID-19: Atypical presentations and favorable outcomes.镰状细胞病与2019冠状病毒病:非典型表现及良好预后
EJHaem. 2020 Aug 4;1(1):338-341. doi: 10.1002/jha2.74. eCollection 2020 Jul.
9
Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20-May 21, 2020.2020 年 3 月 20 日至 5 月 21 日美国镰状细胞病患者中的冠状病毒病。
Emerg Infect Dis. 2020 Oct;26(10):2473-2476. doi: 10.3201/eid2610.202792. Epub 2020 Jul 8.
10
Genomewide Association Study of Severe Covid-19 with Respiratory Failure.全基因组关联研究严重新冠肺炎伴呼吸衰竭。
N Engl J Med. 2020 Oct 15;383(16):1522-1534. doi: 10.1056/NEJMoa2020283. Epub 2020 Jun 17.